Determination of pneumococcal serotypes/genotypes in nasopharyngeal secretions of otitis media children by multiplex PCR
- 105 Downloads
The appropriate clinical applications of pneumococcal polysaccharide vaccines against recent increases in antimicrobial resistant Streptococcus pneumoniae (S. pneumoniae) urgently require accurate analytical methodologies for determining and characterizing the serotypes. The results of current immunological determinations of serotypes with anti-capsular polysaccharide-specific sera are difficult to interpret in terms of quellung changes of the pneumococci. In this study, we applied the multiplex PCR technique for the rapid identification of pneumococci and simultaneous rapid determinations of their serotypes and genotypes that directly correlated with antimicrobial susceptibilities from nasopharyngeal secretions (NPS). Serogroups 6, 19F and 23F were the predominant capsular types of S. pnuemoniae in the NPS samples. Strains of serotypes 19F and 23F frequently had mutations in pbp1a, pbp2x and pbp2b and expressed ermB and mefA; they also were mostly resistant to both penicillin G (PCG) and clarithromycin (CAM). Two NPS samples contained the strain of serotype 19F together with the strain of serotype 23F, although only the strain of serotype 19F was identified by a conventional bacterial culture. Pneumococci were identified in six NPS samples and their serotypes determined by the multiplex PCR, while a conventional bacterial culture failed to identify the pathogens. Our findings suggest that PCR-based serotyping and genotyping can provide an accurate and rapid distribution of pneumococcal serotypes and antimicrobial resistance. The relatively minor populations in the nasopharynx may be determined using molecular techniques.
KeywordsAcute otitis media Genotype Nasopharyngeal secretion Serotype Streptococcus pneumoniae
We gratefully acknowledge the technical assistance rendered by Mrs. Sayeeda Tasnim and Ms. Yuki Tatsumi, Research Assistant of Department of Otolaryngology-Head and Neck Surgery, Wakayama Medical University.
- 3.Bluestone CD, Stephenson JS, Martin LM (1992) Ten-year review of otitis media pathogens. Pediatr Infect Dis J 11[Suppl 8]:7–11Google Scholar
- 6.Hotomi M, Billal DS, Shimada J, Suzumoto M, Yamauchi K, Fujihara K, Yamanaka N (2006) High prevalence of Streptococcus pneumoniae with mutations in pbp1a, pbp2x, and pbp2b genes of penicillin binding proteins in the nasopharynx among children in Japan. ORL J Otorhinolaryngol Relat Spec 68:139–145PubMedGoogle Scholar
- 11.McEllistrem MC, Adams JM, Patel K, Mendelsohn AB, Kaplan SL, Bradley JS, Schutze GE, Kim KS, Mason EO, Wald ER (2005) Acute otitis media due to penicillin-nonsusceptible Streptococcus pneumoniae before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 40:1738–1744PubMedCrossRefGoogle Scholar
- 12.National Committee for Clinical Laboratory Standards (2003). Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 6th edn: approved standard. M7–A6. NCCLS, Villanova, Pa.Google Scholar
- 13.Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, Kohl I, Lommel P, Poolman J, Prieels JP, Schuerman L (2006) Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typeable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367:740–748PubMedCrossRefGoogle Scholar
- 15.Saha SK, Baqui AH, Darmstadt GL, Ruhulamin M, Hanif M, Arifeen SEI, Santosham M, Oishi K, Nagatake T, Black RE (2003) Comparison of antibiotic resistance and serotype composition of carriage and invasive pneumococci among Bangladeshi children: implication of treatment policy and vaccine formulation. J Clin Microbiol 41:5582–5587PubMedCrossRefGoogle Scholar
- 19.Veenhoven R, Bogaert D, Uiterwaal C, Brouwer C, Kiezebrink H, Bruin J, IJzerman E, Hermans P, de Groot R, Zegers B, Kuis W, Rijkers G, Schilder A, Sanders E (2003) Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361:2189–2195PubMedCrossRefGoogle Scholar
- 20.Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A (2003) Active bacterial core surveillance of the emerging infections program network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746PubMedCrossRefGoogle Scholar